Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Pompe disease - overview

Pompe disease - overview

Overview | FAQs | Lysosomal storage disorders

Pompe disease is an inherited disorder marked by a deficiency of the lysosomal enzyme GAA. Though rare, it is debilitating since it reduces the function of muscles, including those required for breathing. Symptoms can appear at any stage of life. Patients experience progressive muscle weakness and difficulty in breathing.

Standard treatment is with Myozyme®.


Myozyme is a registered trademark of Genzyme Corporation.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us